TrialEuropean urology2014

Phase 2 trial of neoadjuvant axitinib in patients with locally advanced nonmetastatic clear cell renal cell carcinoma.

Jose A Karam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.